Live Breaking News & Updates on Next Generation Igg

Stay updated with breaking news from Next generation igg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease

/PRNewswire/ Selecta Biosciences, Inc. (NASDAQ: SELB, President and CEO: Carsten Brunn, Ph.D., "Selecta"), and Astellas Pharma Inc. (TSE: 4503, President. ....

United States , South San Francisco , San Francisco , Kenji Yasukawa , Carsten Brunn , Naoki Okamura , Idexork Xork , Selecta Biosciences , Astellas Pharma Inc , Selecta Biosciences Inc , Astellas Center , Next Generation Igg , Astellas Gene Therapie , Pompe Disease , Astellas Pharma , Late Onset Pompe , Chief Executive Officer , Chief Strategy Officer , Greater Boston , Late Onset Pompe Disease , Focus Area Approach , Gene Therapies , Astellas Pharma Inc ,